Veterinary Medicines

IMOCOLIBOV

Not authorised
  • Escherichia coli, serotypes O9 and O101 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
  • Escherichia coli, serotypes O15 and O8 (antigen 31A), Inactivated
  • Escherichia coli, serotype O78, Inactivated
Download as PDF

Product identification

Medicine name:
IMOCOLIBOV
Active substance:
  • Escherichia coli, serotypes O9 and O101 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
  • Escherichia coli, serotypes O15 and O8 (antigen 31A), Inactivated
  • Escherichia coli, serotype O78, Inactivated
Target species:
  • Cattle (pregnant cow)
  • Sheep (pregnant ewe)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, serotypes O9 and O101 (fimbrial adhesin F5), Inactivated
    0.90
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
    0.90
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotypes O15 and O8 (antigen 31A), Inactivated
    0.90
    haemagglutinating units
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O78, Inactivated
    1.14
    Absorbance Unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle (pregnant cow)
      • Meat and offal
        0
        day
    • Sheep (pregnant ewe)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3152 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download